What is the most likely diagnosis, the key investigations with their interpretations, and the appropriate treatment options for a 26-year-old woman presenting with left lower motor neuron facial nerve palsy, painful red eyes, left ankle arthritis, dry cough, and a violaceous nasal nodule, who is normotensive and non-diabetic?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Most Likely Diagnosis: Sarcoidosis

The clinical presentation of a young woman with lower motor neuron facial nerve palsy, bilateral uveitis (painful red eyes), arthritis, dry cough, and violaceous nasal nodule (lupus pernio) is pathognomonic for sarcoidosis with multisystem involvement.

This constellation of findings represents classic sarcoidosis manifestations across multiple organ systems. The violaceous nasal nodule is highly suggestive of lupus pernio, which is listed as a "highly probable" clinical feature for sarcoidosis 1. The seventh cranial nerve (facial nerve) paralysis is specifically mentioned as a "probable" feature 1. The combination of bilateral uveitis, arthritis, and respiratory symptoms with these dermatologic and neurologic findings makes sarcoidosis the overwhelming diagnostic consideration.

Clinical Reasoning

The patient demonstrates:

  • Neurologic involvement: Lower motor neuron facial palsy (cranial nerve VII)
  • Ocular involvement: Painful red eyes consistent with uveitis (highly probable feature) 1
  • Musculoskeletal involvement: Ankle arthritis (periarticular arthritis pattern)
  • Respiratory involvement: Dry cough suggesting pulmonary sarcoidosis
  • Dermatologic involvement: Violaceous nasal nodule (lupus pernio - highly probable feature) 1

While Bell's palsy accounts for 38% of facial palsies 2, the presence of multiple systemic features excludes idiopathic causes. The young age, female sex, and multisystem involvement are typical for sarcoidosis.

Important Investigations with Interpretations

Essential Diagnostic Workup

Chest Imaging (First-line)

  • Chest X-ray: Look for bilateral hilar lymphadenopathy (highly probable feature) and upper lobe or diffuse infiltrates (probable feature) 1
  • High-resolution CT chest: Assess for perilymphatic nodules (highly probable), peribronchial thickening (probable), and mediastinal/hilar adenopathy 1
  • Interpretation: Bilateral hilar adenopathy with or without parenchymal involvement confirms thoracic sarcoidosis

Tissue Biopsy (Definitive)

  • Target the violaceous nasal nodule (lupus pernio) for skin biopsy - most accessible site
  • Interpretation: Non-caseating granulomas without evidence of infection or malignancy establishes diagnosis 1
  • Alternative sites if needed: transbronchial lung biopsy, lymph node biopsy

Ophthalmologic Examination

  • Slit-lamp examination: Confirm uveitis (anterior, posterior, or panuveitis)
  • Interpretation: Granulomatous uveitis supports sarcoidosis; scleritis and retinitis are also probable features 1

Laboratory Testing

Serum markers:

  • Serum ACE level: Elevated >50% above upper limit of normal is a probable feature 1
    • Caveat: Not specific; can be normal in active disease
  • Serum calcium and 24-hour urine calcium: Hypercalcemia or hypercalciuria with abnormal vitamin D metabolism (normal-to-low PTH, elevated 1,25-dihydroxyvitamin D, normal-to-low 25-hydroxyvitamin D) is highly probable 1
  • Complete blood count: May show lymphopenia
  • Liver function tests: Alkaline phosphatase >3× upper limit of normal is probable 1; assess for hepatic involvement

Additional tests:

  • Bronchoalveolar lavage (BAL) if chest imaging abnormal: Lymphocytosis with elevated CD4:CD8 ratio (>3.5) is a probable feature 1
  • Tuberculin skin test/IGRA: Typically anergic in sarcoidosis; helps exclude tuberculosis

Cardiac Evaluation

  • ECG: Screen for conduction abnormalities (new-onset AV block in young adults is probable) 1
  • Echocardiogram: Assess for reduced LVEF with no risk factors 1
  • Cardiac MRI: If cardiac symptoms or ECG abnormalities - shows gadolinium enhancement indicating inflammatory activity 1

Neurologic Imaging

  • MRI brain with gadolinium: Assess extent of neurosarcoidosis; gadolinium enhancement of CNS structures is highly probable 1
  • Interpretation: May show cranial nerve enhancement, leptomeningeal involvement

Treatment Options

Systemic Corticosteroids - First-line Therapy

Prednisone 0.5-1 mg/kg/day (typically 40-60 mg daily) for 4-6 weeks, then gradual taper over 6-12 months is the standard initial treatment for symptomatic multisystem sarcoidosis with neurologic and ocular involvement.

Rationale for Treatment

  • Neurologic involvement (facial palsy) requires aggressive treatment to prevent permanent nerve damage
  • Ocular involvement (uveitis) requires treatment to prevent vision loss
  • Symptomatic pulmonary disease warrants therapy
  • Multiple organ involvement indicates need for systemic rather than topical therapy

Treatment Algorithm

Immediate therapy (within days of diagnosis):

  1. Oral prednisone 40-60 mg daily (or 0.5-1 mg/kg)
  2. Topical corticosteroid eye drops in conjunction with systemic therapy for uveitis
  3. Ophthalmology co-management for uveitis monitoring

Maintenance phase (after 4-6 weeks):

  • Taper prednisone by 5-10 mg every 2-4 weeks based on clinical response
  • Target maintenance dose: 5-10 mg daily for 6-12 months total
  • Monitor for relapse during taper

Steroid-sparing agents (if inadequate response or steroid toxicity):

  • Methotrexate 10-25 mg weekly (most common second-line agent)
  • Azathioprine 50-200 mg daily
  • Mycophenolate mofetil 1000-3000 mg daily
  • Anti-TNF biologics (infliximab, adalimumab) for refractory neurosarcoidosis

Monitoring During Treatment

  • Monthly clinical assessment of facial nerve function, vision, respiratory symptoms
  • Chest X-ray every 3-6 months to assess pulmonary response
  • Serum calcium and renal function every 3 months (hypercalcemia risk)
  • Ophthalmology follow-up every 1-3 months for uveitis
  • Bone density monitoring if prolonged corticosteroid use

Common Pitfalls to Avoid

  • Do not delay treatment waiting for biopsy if clinical presentation is classic - facial nerve damage may become permanent
  • Do not undertreated neurosarcoidosis - requires higher doses and longer duration than isolated pulmonary disease
  • Do not stop steroids abruptly - risk of rebound inflammation and adrenal insufficiency
  • Do not miss cardiac involvement - perform ECG and consider cardiac MRI as cardiac sarcoidosis can cause sudden death
  • Do not attribute all facial palsies to Bell's palsy - the presence of systemic features mandates investigation for secondary causes 2

References

1
Guideline

diagnosis and detection of sarcoidosis. an official american thoracic society clinical practice guideline.

American Journal of Respiratory and Critical Care Medicine, 2020

Related Questions

What is the appropriate evaluation and management for a 45-year-old man presenting with right-sided tinnitus, hearing loss, vertigo, and facial paralysis?
In a 57-year-old woman presenting with right-sided headache and right facial numbness, what is the appropriate diagnostic work-up and initial management?
How should a 69-year-old man with left facial (mouth and lip) numbness and left hand weakness be evaluated and managed?
In an 88-year-old woman with chronic headaches and hypertension treated with olmesartan, hydrochlorothiazide, and labetalol, who completed a 5‑day prednisone course for a right‑ear infection 10 days ago and now presents with a worsening headache and burning sensation in the ear, what is the appropriate evaluation and management?
What is the appropriate urgent evaluation and management for a patient with acute onset left-sided facial numbness starting at the eye and extending downward?
What is the recommended dosage and frequency for dexamethasone 0.1% ophthalmic drops for ocular inflammation?
Which operating‑room shift should be assigned to a patient scheduled for surgical debridement of a postoperative wound infection in a facility with six operating rooms?
What is the recommended folic acid supplementation dose and schedule for patients with polycythemia vera, especially those receiving cytoreductive therapy or undergoing frequent phlebotomy?
Should I undergo an echocardiogram for unstable angina?
What is the Stupp protocol for treating newly diagnosed glioblastoma in adults?
Is it safe to take Unisom (diphenhydramine or doxylamine) the night before an endoscopy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.